Skip to main content
Have a personal or library account? Click to login
Investigation of the effects of chronic L-arginine supplementation on paraoxonase-1 activity in high-cholesterol diet-induced hypercholesterolemia model in rats Cover

Investigation of the effects of chronic L-arginine supplementation on paraoxonase-1 activity in high-cholesterol diet-induced hypercholesterolemia model in rats

Open Access
|Apr 2026

References

  1. Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022;145(8):e153-e639.
  2. Jebari-Benslaiman S, Galicia-Garcia U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, et al. Pathophysiology of Atherosclerosis. Int J Mol Sci. 2022;23(6). DOI: 10.3390/ijms23063346
  3. Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 2020;41(24):2313-30. DOI: 10.1093/eurheartj/ehz962
  4. Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J Mol Sci. 2020;21(5). DOI: 10.3390/ijms21051835
  5. Zhao Y, Qu H, Wang Y, Xiao W, Zhang Y, Shi D. Small rodent models of atherosclerosis. Biomed Pharmacother. 2020;129:110426. DOI: 10.1016/j.biopha.2020.110426
  6. Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond). 2018;132(12):1243-52. DOI: 10.1042/CS20180306
  7. Ginsberg HN, Packard CJ, Chapman MJ, Borén J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. European Heart Journal. 2021;42(47):4791-806. DOI: 10.1093/eurheartj/ehab551
  8. Langlois MR, Nordestgaard BG, Langsted A, Chapman MJ, Aakre KM, Baum H, et al. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med. 2020;58(4):496-517. DOI: 10.1515/cclm-2019-1253
  9. Kattoor AJ, Kanuri SH, Mehta JL. Role of Ox-LDL and LOX-1 in Atherogenesis. Curr Med Chem. 2019;26(9):1693-700. DOI: 10. 2174/0929867325666180508100950
  10. Mackness M, Mackness B. Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles. Gene. 2015;567(1):12-21. DOI: 10.1016/j. gene.2015.04.088
  11. Taler-Vercic A, Golicnik M, Bavec A. The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3. Molecules. 2020;25(24). DOI: 10.3390/molecules25245980
  12. Ferreira CER, Haas CS, Goularte KL, Rovani MT, Cardoso FF, Schneider A, et al. Expression of paraoxonase types 1, 2 and 3 in reproductive tissues and activity of paraoxonase type 1 in the serum and seminal plasma of bulls. Andrologia. 2018;50(3). DOI: 10.1111/and.12923
  13. Gugliucci A, Menini T. Paraoxonase 1 and HDL maturation. Clinica Chimica Acta. 2015;439:5-13. DOI: 10.1016/j.cca.2014.09.016
  14. Manning PJ, Jong SA, Ryalls AR, Sutherland WH. Paraoxonase 1 activity in chylomicrons and VLDL: the effect of type 2 diabetes and meals rich in saturated fat and oleic acid. Lipids. 2012;47(3):259-67. DOI: 10.1007/s11745-011-3640-3
  15. Bassu S, Mangoni AA, Argiolas D, Carru C, Pirina P, Fois AG, et al. A systematic review and meta-analysis of paraoxonase-1 activity in asthma. Clinical and Experimental Medicine. 2022;23(4):1067-74. DOI: 10.1007/s10238-022-00930-0
  16. Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative Stress in Atherosclerosis. Curr Atheroscler Rep. 2017;19(11):42. DOI: 10.1007/s11883-017-0678-6
  17. Antosova M, Buday T, Plevkova J. L-arginine and nitric oxide homeostasis. L-Arginine: Structure, Dietary Sources and Beneficial Effects: Nova Science Publishers, Inc.; 2016. p. 47-73.
  18. Galluccio E, Spadoni S, Fontana B, Bosi E, Piatti P, Monti LD. Long lasting protective effects of early L-arginine treatment on endothelium in an in vitro study. Clin Nutr. 2021;40(4):1519-29. DOI: 10.1016/j.clnu.2021.02.040
  19. Wu G, Meininger CJ, McNeal CJ, Bazer FW, Rhoads JM. Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans. Adv Exp Med Biol. 2021;1332:167-87. DOI: 10.1007/978-3-030-74180-8_10
  20. Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol. 2023;97(10):2499-574. DOI: 10.1007/s00204-023-03562-9
  21. Ito F, Sono Y, Ito T. Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation. Antioxidants (Basel). 2019;8(3). DOI: 10.3390/antiox8030072
  22. Martinez Alvarez JR, Lopez Jaen AB, Cavia-Saiz M, Muniz P, Valls-Belles V. Beneficial Effects of Olive Oil Enriched with Lycopene on the Plasma Antioxidant and Anti-Inflammatory Profile of Hypercholesterolemic Patients. Antioxidants (Basel). 2023;12(7). DOI: 10.3390/antiox12071458
  23. National Research Council. 2011. Guide for the Care and Use of Laboratory Animals: Eighth Edition. Washington, DC: The National Academies Press. Available at: https://nap.nationalacademies.org/resource/12910/guide-for-the-care-and-use-of-laboratory-animals-digital/ (Accessed: 13 January 2026).
  24. Ghasemi M, Dehpour AR. Ethical considerations in animal studies. J Med Ethics Hist Med. 2009;2:12.
  25. Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit. 2005;11(7):BR228-34.
  26. Barnard DE, Lewis SM, Teter BB, Thigpen JE. Open- and closed-formula laboratory animal diets and their importance to research. J Am Assoc Lab Anim Sci. 2009;48(6):709-13.
  27. Emekli-Alturfan E, Kasikci E, Yarat A. Peanuts improve blood glutathione, HDL-cholesterol level and change tissue factor activity in rats fed a high-cholesterol diet. European Journal of Nutrition. 2007;46(8):476-82. DOI: 10.1007/s00394-007-0688-1
  28. Xiao DS, Jiang L, Che LL, Lu L. Nitric oxide and iron metabolism in exercised rat with L-arginine supplementation. Mol Cell Biochem. 2003;252(1-2):65-72. DOI: 10.1023/A:1025517216681
  29. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351-8. DOI: 10.1016/0003-2697(79)90738-3
  30. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis. 1991;86(2-3):193-9. DOI: 10.1016/0021-9150(91)90215-O
  31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. DOI: 10.1093/clinchem/18.6.499
  32. Kalelioglu T, Genc A, Karamustafalioglu N, Emul M. Assessment of cardiovascular risk via atherogenic indices in patients with bipolar disorder manic episode and alterations with treatment. Diabetes Metab Syndr. 2017;11 Suppl 1:S473-S5. DOI: 10.1016/j. dsx.2017.03.038
  33. Quispe R, Elshazly MB, Zhao D, Toth PP, Puri R, Virani SS, et al. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. Eur J Prev Cardiol. 2020;27(15):1597-605. DOI: 10.1177/2047487319862401
  34. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987;68(3):231-40. DOI: 10.1016/0021-9150(87)90202-4
  35. Sadeghi-Hashjin G, Abuhosseini M, Asri-Rezaei S. Basic researchRole of nitric oxide in the plasma lipid profile in the rabbits. Archives of Medical Science. 2009;5(3):308-12.
  36. Pai MH, Huang KH, Wu CH, Yeh SL. Effects of dietary arginine on inflammatory mediator and receptor of advanced glycation endproducts (RAGE) expression in rats with streptozotocin-induced type 2 diabetes. Br J Nutr. 2010;104(5):686-92. DOI: 10.1017/S000711451000111X
  37. Javrushyan H, Nadiryan E, Grigoryan A, Avtandilyan N, Maloyan A. Antihyperglycemic activity of L-norvaline and L-arginine in high-fat diet and streptozotocin-treated male rats. Exp Mol Pathol. 2022;126:104763. DOI: 10.1016/j.yexmp.2022.104763
  38. Martins MA, Catta-Preta M, Mandarim-de-Lacerda CA, Aguila MB, Brunini TC, Mendes-Ribeiro AC. High fat diets modulate nitric oxide biosynthesis and antioxidant defence in red blood cells from C57BL/6 mice. Arch Biochem Biophys. 2010;499(1-2):56-61. DOI: 10.1016/j.abb.2010.04.025
  39. Jabecka A, Ast J, Bogdaski P, Drozdowski M, Pawlak-Lemaska K, Cielewicz AR, et al. Oral L-arginine supplementation in patients with mild arterial hypertension and its effect on plasma level of asymmetric dimethylarginine, L-citruline, L-arginine and antioxidant status. Eur Rev Med Pharmacol Sci. 2012;16(12):1665-74.
  40. Mazloom Z, Dashtabi A, Fararouei M, Hejazi N. Oral L-arginine administration improves anthropometric and biochemical indices associated with cardiovascular diseases in obese patients: A randomized, single blind placebo controlled clinical trial. Research in Cardiovascular Medicine. 2016;5(1). DOI: 10.4103/2251-9572.218698
  41. Mirmiran P, Bahadoran Z, Ghasemi A, Azizi F. The Association of Dietary l-Arginine Intake and Serum Nitric Oxide Metabolites in Adults: A Population-Based Study. Nutrients. 2016;8(5). DOI: 10.3390/nu8050311
  42. Shan L, Wang B, Gao G, Cao W, Zhang Y. L-Arginine supplementation improves antioxidant defenses through L-arginine/nitric oxide pathways in exercised rats. J Appl Physiol (1985). 2013;115(8):1146-55. DOI: 10.1152/japplphysiol.00225.2013
  43. Aluko EO, Omobowale TO, Oyagbemi AA, Adejumobi OA, Ajibade TO, Fasanmade AA. Reduction in nitric oxide bioavailability shifts serum lipid content towards atherogenic lipoprotein in rats. Biomed Pharmacother. 2018;101:792-7. DOI: 10.1016/j. biopha.2018.03.001
  44. Choi JW. Enhanced nitric oxide production is closely associated with serum lipid concentrations in adolescents. Clinica Chimica Acta. 2004;347(1-2):151-6. DOI: 10.1016/j.cccn.2004.04.024
  45. Sepandi M, Abbaszadeh S, Qobady S, Taghdir M. Effect of L-Arginine supplementation on lipid profiles and inflammatory markers: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2019;148:104407. DOI: 10.1016/j.phrs.2019.104407
  46. Siani A, Pagano E, Iacone R, Iacoviello L, Scopacasa F, Strazzullo P. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens. 2000;13(5 Pt 1):547-51. DOI: 10.1016/S0895-7061(99)00233-2
  47. I. Harisa GE-d. L-Arginine Ameliorates Arylesterase/Paraoxonase Activity of Paraoxonase-1 in Hypercholesterolemic Rats. Asian Journal of Biochemistry. 2011;6(3):263-72. DOI: 10.3923/ajb.2011.263.272
  48. Kim DS, Burt AA, Ranchalis JE, Richter RJ, Marshall JK, Nakayama KS, et al. Dietary cholesterol increases paraoxonase 1 enzyme activity. J Lipid Res. 2012;53(11):2450-8. DOI: 10.1194/jlr.P030601
  49. Mahrooz A, Zargari M, Sedighi O, Shaygani H, Gohari G. Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis. Clin Invest Med. 2012;35(3):E144-51. DOI: 10.25011/cim.v35i3.16590
  50. Tward A, Xia YR, Wang XP, Shi YS, Park C, Castellani LW, et al. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation. 2002;106(4):484-90. DOI: 10.1161/01.CIR.0000023623.87083.4F
  51. Al-Rejaie SS, Aleisa AM, Sayed-Ahmed MM, Al-Shabanah OA, Abuohashish HM, Ahmed MM, et al. Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat. BMC Complement Altern Med. 2013;13:136. DOI: 10.1186/1472-6882-13-136
  52. Jiang C, Chen M, Wu Y, Bai H, Liu X, Fan P. Longitudinal changes of oxidative stress and PON1 lactonase activity and status in older pregnant women undergoing assisted reproductive technology: a prospective nested case-control study. Reprod Biol Endocrinol. 2023;21(1):97. DOI: 10.1186/s12958-023-01139-w
  53. Zhou M, Liu XH, Liu QQ, Chen M, Bai H, Jiang CY, et al. Lactonase activity and status of paraoxonase 1 and oxidative stress in neonates of women with gestational diabetes mellitus. Pediatr Res. 2021;89(5):1192-9. DOI: 10.1038/s41390-020-1023-2
  54. Khazaei M, Mobarakeh J, Rahimi A, Razavi M. Effect of chronic L-Arginine supplementation on aortic fatty streak formation and serum nitric oxide concentration in normal and high-cholesterol fed rabbits. Acta Physiologica Hungarica. 2012;99(1):87-93. DOI: 10.1556/APhysiol.99.2012.1.9
  55. Boesch-Saadatmandi C, Niering J, Minihane AM, Wiswedel I, Gardeman A, Wolffram S, et al. Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice. Atherosclerosis. 2010;211(1):110-3. DOI: 10.1016/j.atherosclerosis.2010.02.027
  56. Zhang H, Wang L, Peng F, Wang X, Gong H. L-Arginine Ameliorates High-Fat Diet-Induced Atherosclerosis by Downregulating miR-221. Biomed Res Int. 2020;2020:4291327. DOI: 10.1155/2020/4291327
  57. Sri Iswari R, Dafip M, Purwantoyo E. Malondialdehyde (MDA) Production in Atherosclerosis Supplemented with Steamed Tomato. Pak J Biol Sci. 2021;24(3):319-25. DOI: 10.3923/pjbs.2021.319.325
  58. Tabansi D, Dahiru D, Patrick AT, Jahng WJ. Anti-Atherosclerosis and Anti-Hyperlipidemia Functions of Terminalia catappa Fruit. ACS Omega. 2023;8(39):35571-9. DOI: 10.1021/acsomega.3c00685
  59. Sanchez-Muniz FJ, Bastida S. Do not use the Friedewald formula to calculate LDL-cholesterol in hypercholesterolaemic rats. Eur J Lipid Sci Technol [Internet]. 2008 Apr 1;110(4):295-301. DOI: 10.1002/ejlt.200700280
DOI: https://doi.org/10.2478/rrlm-2026-0015 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 167 - 178
Submitted on: Jan 12, 2026
Accepted on: Feb 23, 2026
Published on: Apr 24, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Ozgur Doga Ozsoy, Selda Uzgur, Fatih Hunc, Sevgi Eskiocak, Semsi Altaner, Simla Olgac, Selma Suer Gokmen, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.